# Arbutus Biopharma Corp: Form 8-K, filed Feb 19, 2020

- Company: [Arbutus Biopharma Corp](/companies/abus.md) (CIK 1447028)
- Form: 8-K
- Filed: 2020-02-19
- Accepted by EDGAR: Feb 19, 2020, 08:00 ET
- Period: 2020-02-19
- Accession: 0001447028-20-000024
- Inline XBRL: no
- Main document: https://www.sec.gov/Archives/edgar/data/1447028/000144702820000024/a2020-02xdirectorchange8xk.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1447028/000144702820000024/

## Items reported

- Item 5.02: Departure or appointment of officers or directors

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1447028/000144702820000024/a2020-02xdirectorchange8xk.htm

Filed Feb 19, 2020.
Source: SEC EDGAR, the filing index for accession 0001447028-20-000024. Last ingested by Listed: Nov 12, 2026, 17:55 ET. No prices; not investment advice.
